Pancreatic Cancer Research

ResearcherConsejo Superior de Investigaciones CientíficasActive in the last 2 years

Juan Carlos López-Gil

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4988-8648; OpenAlex author ID A5044829130. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
62
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 2 papers

Papers 9

  1. U2 snRNP inhibition hampers pancreatic cancer cell viability by disrupting DNA repair proficiency and mitotic checkpoint integrity Co-author DOI 10.1186/s13046-026-03795-3↗
  2. High-fat diet imprints a macrophage-tumor CAMP-P2RX7 axis driving pancreatic cancer initiation, plasticity and metastasis First author DOI 10.64898/2026.02.10.703309↗
  3. A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance. Co-author DOI 10.1073/pnas.2523039122↗
  4. c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT. Co-author DOI 10.1186/s12943-025-02486-5↗
  5. The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells. Co-author DOI 10.1136/gutjnl-2023-330995↗
  6. Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis. Co-author DOI 10.1186/s12951-024-03010-5↗
  7. Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/gutjnl-2021-325564↗
  8. Targeting SRC Kinase Signaling in Pancreatic Cancer Stem Cells. Co-author DOI 10.3390/ijms21207437↗
  9. Correction: Alcalá, S., et al. Targeting SRC Kinase Signaling in Pancreatic Cancer Stem Cells. Int. J. Mol. Sci. 2020, 21, 7437. Co-author DOI 10.3390/ijms21239215↗

Closest collaborators

The 25 strongest of 62 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bruno Sáinz · 8 shared papers, 2020–2026 · strength 1.25
  2. Sonia Alcalá · 7 shared papers, 2020–2026 · strength 1.06
  3. Carmen E. Guerra · 4 shared papers, 2024–2026 · strength 0.78
  4. Christopher Heeschen · 4 shared papers, 2020–2024 · strength 0.51
  5. Julie Earl · 3 shared papers, 2023–2026 · strength 0.47
  6. Ana Galván-del-Rey · 2 shared papers, 2026 · strength 0.46
  7. Mariano Barbacid · 2 shared papers, 2025–2026 · strength 0.39
  8. Patricia Sancho Andrés · 2 shared papers, 2023–2026 · strength 0.33
  9. Adrián Palencia‐Campos · 2 shared papers, 2024 · strength 0.32
  10. Patrick Christian Hermann · 2 shared papers, 2023–2024 · strength 0.30
  11. Kıvanç Görgülü · 2 shared papers, 2023–2025 · strength 0.29
  12. Hana Algül · 2 shared papers, 2023–2025 · strength 0.29
  13. Alfredo Carrato Mena · 2 shared papers, 2023–2024 · strength 0.26
  14. Giuseppe Quero · 1 shared paper, 2026 · strength 0.25
  15. Valentina Panzeri · 1 shared paper, 2026 · strength 0.25
  16. Claudio Sette · 1 shared paper, 2026 · strength 0.25
  17. Veronica Ruta · 1 shared paper, 2026 · strength 0.25
  18. Beatriz Parejo-Alonso · 1 shared paper, 2026 · strength 0.21
  19. Antonio Agostini · 1 shared paper, 2026 · strength 0.21
  20. Lívia Archibugi · 1 shared paper, 2026 · strength 0.21
  21. Pilar Acedo Núñez · 1 shared paper, 2026 · strength 0.21
  22. Claudio Luchini · 1 shared paper, 2026 · strength 0.21
  23. Gabriele Capurso · 1 shared paper, 2026 · strength 0.21
  24. Carmine Carbone · 1 shared paper, 2026 · strength 0.21
  25. Stephen P. Pereira · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.